United Therapeutics
UTHR
UTHR
373 hedge funds and large institutions have $6.01B invested in United Therapeutics in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 155 increasing their positions, 130 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
50% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 62
74% less call options, than puts
Call options by funds: $29.9M | Put options by funds: $114M
Holders
373
Holding in Top 10
5
Calls
$29.9M
Puts
$114M
Top Buyers
| 1 | +$58.7M | |
| 2 | +$55.9M | |
| 3 | +$54.6M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$49M |
| 5 |
Renaissance Technologies
New York
|
+$43M |
Top Sellers
| 1 | -$216M | |
| 2 | -$112M | |
| 3 | -$103M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$86.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$43.2M |